Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pawlitzki

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Multiple Sclerosis and Related Disorders|February 12, 2022
A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumabSaskia Räuber, Marc Pawlitzki, Melanie Korsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 17, 2024
Abatacept Induces Long-Term Reconstitution of the B-Cell Niche in a Patient With CTLA-4 Haploinsufficiency: A Case ReportSteffen Pfeuffer, Christopher Nelke, Marc Pawlitzki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2021
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumabSteffen Pfeuffer, Tobias Ruck, Refik Pul, et al.
Journal of Central Nervous System Disease|February 16, 2026
Case-Based Lessons on Remote Patient Monitoring in Neurology Using Consumer-Grade WearablesPaula Z Epping, Ramona Hagler, Noah M Werner, et al.
Neurological Research and Practice|May 18, 2025
From routine to selective: how updated MRI guidelines reshape gadolinium use in GermanyMarc Pawlitzki, Alexander Stahmann, Niklas Frahm, et al.
Journal of Neuromuscular Diseases|March 19, 2026
Semi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathiesYana Leven, Suam Kim, Antoine Sanner, et al.
International Journal of Molecular Sciences|December 5, 2019
Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever VaccinationLeoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Children (Basel, Switzerland)|September 28, 2021
Clinical Course, Myopathology and Challenge of Therapeutic Intervention in Pediatric Patients with Autoimmune-Mediated Necrotizing MyopathyAdela Della Marina, Marc Pawlitzki, Tobias Ruck, et al.
Neurological Research and Practice|June 13, 2026
Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoringNoah M Werner, Melanie Schuette, Ramona Hagler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2020
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patientsTilman Schneider-Hohendorf, Andreas Schulte-Mecklenbeck, Patrick Ostkamp, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis and Related Disorders|February 12, 2022
A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumabSaskia Räuber, Marc Pawlitzki, Melanie Korsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 17, 2024
Abatacept Induces Long-Term Reconstitution of the B-Cell Niche in a Patient With CTLA-4 Haploinsufficiency: A Case ReportSteffen Pfeuffer, Christopher Nelke, Marc Pawlitzki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2021
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumabSteffen Pfeuffer, Tobias Ruck, Refik Pul, et al.
Journal of Central Nervous System Disease|February 16, 2026
Case-Based Lessons on Remote Patient Monitoring in Neurology Using Consumer-Grade WearablesPaula Z Epping, Ramona Hagler, Noah M Werner, et al.
Neurological Research and Practice|May 18, 2025
From routine to selective: how updated MRI guidelines reshape gadolinium use in GermanyMarc Pawlitzki, Alexander Stahmann, Niklas Frahm, et al.
Journal of Neuromuscular Diseases|March 19, 2026
Semi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathiesYana Leven, Suam Kim, Antoine Sanner, et al.
International Journal of Molecular Sciences|December 5, 2019
Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever VaccinationLeoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Children (Basel, Switzerland)|September 28, 2021
Clinical Course, Myopathology and Challenge of Therapeutic Intervention in Pediatric Patients with Autoimmune-Mediated Necrotizing MyopathyAdela Della Marina, Marc Pawlitzki, Tobias Ruck, et al.
Neurological Research and Practice|June 13, 2026
Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoringNoah M Werner, Melanie Schuette, Ramona Hagler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2020
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patientsTilman Schneider-Hohendorf, Andreas Schulte-Mecklenbeck, Patrick Ostkamp, et al.
Pageof 14